Direkt zum Inhalt
Merck
  • Effects of fibrinogen concentration on fibrin glue and bone powder scaffolds in bone regeneration.

Effects of fibrinogen concentration on fibrin glue and bone powder scaffolds in bone regeneration.

Journal of bioscience and bioengineering (2014-04-29)
Beom-Su Kim, Hark-Mo Sung, Hyung-Keun You, Jun Lee
ZUSAMMENFASSUNG

Fibrin polymers are widely used in the tissue engineering field as biomaterials. Although numerous researchers have studied the fabrication of scaffolds using fibrin glue (FG) and bone powder, the effects of varied fibrinogen content during the fabrication of scaffolds on human mesenchymal stem cells (hMSCs) and bone regeneration remain poorly understood. In this study, we formulated scaffolds using demineralized bone powder and various fibrinogen concentrations and analyzed the microstructure and mechanical properties. Cell proliferation, cell viability, and osteoblast differentiation assays were performed. The ability of the scaffold to enhance bone regeneration was evaluated using a rabbit calvarial defect model. Micro-computed tomography (micro-CT) showed that bone powders were uniformly distributed on the scaffolds, and scanning electron microscopy (SEM) showed that the fibrin networks and flattened fibrin layers connected adjacent bone powder particles. When an 80 mg/mL fibrinogen solution was used to formulate scaffolds, the porosity decreased 41.6 ± 3.6%, while the compressive strength increased 1.16 ± 0.02 Mpa, when compared with the values for the 10 mg/mL fibrinogen solution. Proliferation assays and SEM showed that the scaffolds prepared using higher fibrinogen concentrations supported and enhanced cell adhesion and proliferation. In addition, mRNA expression of alkaline phosphatase and osteocalcin in cells grown on the scaffolds increased with increasing fibrinogen concentration. Micro-CT and histological analysis revealed that newly formed bone was stimulated in the scaffold implantation group. Our results demonstrate that optimization of the fibrinogen content of fibrin glue/bone powder scaffolds will be beneficial for bone tissue engineering.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Fibrinogen aus Rinderplasma, Type I-S, 65-85% protein (≥75% of protein is clottable)
Sigma-Aldrich
Fibrinogen aus Humanplasma, 50-70% protein (≥80% of protein is clottable)
Sigma-Aldrich
Phosphatase, alkalisch aus Rinderdarmschleimhaut, buffered aqueous solution, ≥2,000 DEA units/mg protein
Sigma-Aldrich
Fibrinogen aus Humanplasma, 35-65% protein (≥90% of protein is clottable).
Sigma-Aldrich
Phosphatase, alkalisch aus Rinderdarmschleimhaut, lyophilized powder, ≥10 DEA units/mg solid
Sigma-Aldrich
Phosphatase, alkalisch aus Rinderdarmschleimhaut, BioUltra, ≥5,700 DEA units/mg protein
Sigma-Aldrich
Fibrin aus Humanplasma, insoluble powder
Sigma-Aldrich
Phosphatase, alkalisch aus E. coli, lyophilized powder, 30-60 units/mg protein (in glycine buffer)
Sigma-Aldrich
Fibrinogen from rat plasma, 60-80% protein (≥60% of protein is clottable)
Sigma-Aldrich
Phosphatase, alkalisch aus Rinderdarmschleimhaut, ≥5,500 DEA units/mg protein
Sigma-Aldrich
Phosphatase, alkalisch aus E. coli, buffered aqueous glycerol solution, 20-50 units/mg protein (in glycine buffer)
Sigma-Aldrich
Phosphatase, alkalisch aus Rinderdarmschleimhaut, buffered aqueous glycerol solution, ≥4,000 DEA units/mg protein
Sigma-Aldrich
Phosphatase, alkalisch aus E. coli, ammonium sulfate suspension, 30-90 units/mg protein (modified Warburg-Christian, in glycine buffer)
Sigma-Aldrich
Phosphatase, alkalisch aus Schweineniere, lyophilized powder, ≥100 DEA units/mg protein
Sigma-Aldrich
Phosphatase, alkalisch aus Kälberdarmschleimhaut, suitable for enzyme immunoassay, solution (clear, colorless), ~2500 U/mg protein (~10 mg/ml)
Sigma-Aldrich
Phosphatase, alkalische Garnelen, ≥900 DEA units/mL, buffered aqueous glycerol solution, recombinant, expressed in proprietary host
Sigma-Aldrich
Phosphatase, alkalisch Rind, recombinant, expressed in Pichia pastoris, ≥4000 units/mg protein